Iovance Biotherapeutics Market Cap

Iovance Biotherapeutics has a market cap or net worth of 462.61 million as of July 11, 2025. Its market cap has decreased by -75.21% in one year.

Market Cap

462.61M

Enterprise Value

235.93M

Revenue

164.61M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.91

Market Cap Chart

Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 62.39M to 462.61M, an increase of 641.51%. That is a compound annual growth rate of 14.15%.

Market Cap History

Date	Market Cap	% Change
Jul 11, 2025	462.61M	-74.32%
Dec 31, 2024	1.80B	10.29%
Dec 29, 2023	1.63B	95.13%
Dec 30, 2022	837.09M	-62.16%
Dec 31, 2021	2.21B	-55.63%
Dec 31, 2020	4.99B	89.02%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	162.05B
GSK plc	56.99B
Haleon	33.01B
Smith & Nephew	9.82B
ConvaTec Group	5.33B
Hikma Pharmaceuticals	4.32B
HUTCHMED (China)	2.02B
Genus	1.46B

Market Cap Rankings